Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August

·

·

Vir Biotech to begin mid-to-late stage study of COVID-19 drug candidate in August

(Reuters) – Vir Biotechnology Inc said on Tuesday it plans to start a mid-to-late stage trial of its COVID-19 drug candidate in August, as drugmakers across the globe rush to find treatments for the highly infectious virus. The company’s therapy candidate, …
See Original Article

Tesla announces 5 for 1 share split, rallies 8%

Today after the close of regular trading Tesla, a well-known American electric vehicle company, announced that it intends to split its shares 5 for 1. The split announcement comes after a sharp rally in the value of Tesla equity in recent quarters. The company’s …
See Original Article

TikTok collected device identifiers for over a year in violation of Android policies

TikTok’s Android app collected users’ MAC addresses for 18 months in violation of the platform rules, as discovered by a Wall Street Journal investigation on Tuesday. The addresses would have served as a unique identifier for each user’s device, making …
See Original Article

Oil dips lower after facing resistance at key technical level

Crude closed lower after failing to hold above a key technical level as a still-raging pandemic threatens to depress demand into the fall. Futures in New York declined 0.8% on Tuesday as oil met resistance at its 200-day moving average. Meanwhile, virus …
See Original Article

Boeing 737 MAX cancellations rise, deliveries drop as crises drag on

(Reuters) – Boeing Co customers scrubbed more than 400 orders for the U.S. planemaker’s grounded 737 MAX jets this year, while the company’s overall aircraft deliveries slumped to only four in July, monthly numbers showed on Tuesday. FILE PHOTO: …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.